Home » Topics » Regulatory » Patents

Patents
RSS

Kainos Medicine presents Brd4 inhibitors

Dec. 2, 2016

Medshine Discovery develops PDE2A inhibitors and TNF-alpha production inhibitors

Dec. 2, 2016

GlaxoSmithKline describes RIP-1 kinase 1 inhibitors

Dec. 2, 2016

Wistar Institute discloses EBNA-1 inhibitors

Dec. 2, 2016

Kalyra Pharmaceuticals patents EGFR inhibitors

Dec. 2, 2016

Boehringer Ingelheim prepares and tests IGF-1R inhibitors

Dec. 1, 2016

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Selvita reports PFKFB inhibitors in patent

Dec. 1, 2016

Australian institutes describe IRAP inhibitors

Dec. 1, 2016

Tangrun Pharmaceuticals patents agents for HCV infection

Dec. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...